Clinical Trial Detail

NCT ID NCT02142530
Title Carfilzomib Plus Belinostat in Relapsed/Refractory NHL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Massachusetts General Hospital
Indications

non-Hodgkin lymphoma

Therapies

Belinostat

Carfilzomib

Age Groups: adult

No variant requirements are available.